Two New Directors Added To Mindray Board In China
This article was originally published in PharmAsia News
Executive Summary
China's Mindray Medical International has appointed two men knowledgeable in finances to its board of director. Peter Wan and Kern Lim will hold new seats on an expanded nine-member board and will serve on the Mindray board's committee overseeing corporate governance and compensation. Wan is a certified public accountant formerly with Pricewaterhouse Coopers and Lim, also a CPA, is a finance vice president at a Macao hotel. (Click here for more